Production (Stage)
Sabra Health Care REIT, Inc.
SBRA
$17.44
$0.352.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.65% | 1.39% | -2.09% | -0.18% | -3.72% |
| Total Other Revenue | 20.60% | 20.01% | 69.71% | 76.39% | 88.08% |
| Total Revenue | 10.90% | 9.14% | 20.68% | 22.99% | 21.68% |
| Cost of Revenue | 15.23% | 15.90% | 13.94% | 13.61% | 17.43% |
| Gross Profit | 8.95% | 6.20% | 24.09% | 27.75% | 23.69% |
| SG&A Expenses | 4.19% | 5.47% | 28.98% | 28.37% | 23.14% |
| Depreciation & Amortization | -1.72% | -7.35% | -10.49% | -12.15% | -11.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.03% | 4.74% | 4.41% | 3.04% | 4.16% |
| Operating Income | 18.13% | 17.71% | 68.19% | 89.91% | 77.49% |
| Income Before Tax | 176.68% | 710.49% | 213.35% | 144.53% | 140.65% |
| Income Tax Expenses | -44.12% | -49.80% | -31.54% | 4.61% | 2.43% |
| Earnings from Continuing Operations | 184.38% | 821.14% | 209.99% | 142.40% | 138.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 184.38% | 821.14% | 209.99% | 142.40% | 138.76% |
| EBIT | 18.13% | 17.71% | 68.19% | 89.91% | 77.49% |
| EBITDA | 9.91% | 6.62% | 24.20% | 28.51% | 24.51% |
| EPS Basic | 179.29% | 809.92% | 209.33% | 142.29% | 138.70% |
| Normalized Basic EPS | 35.93% | 36.03% | 348.05% | 961.76% | 628.74% |
| EPS Diluted | 197.25% | 995.29% | 204.07% | 138.78% | 135.61% |
| Normalized Diluted EPS | 35.12% | 34.97% | 345.36% | 964.69% | 630.17% |
| Average Basic Shares Outstanding | 1.65% | 0.99% | 0.43% | 0.13% | 0.11% |
| Average Diluted Shares Outstanding | 2.23% | 1.72% | 1.27% | 0.67% | 0.56% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.64% | -0.89% | 1.91% | 3.36% | 3.58% |